Micropep Raises €8.75M in Funding

Micropep, a Toulouse, France-based ag-biotech company developing biological micropeptide-based solutions for agriculture, closed an €8.75m Series A1 financing round.

The round was led by Fall Line Capital with participation from existing investors Supernova Invest, Sofinnova Partners, FMC Ventures and IRDI/SORIDEC.

The company intends to use the funds to accelerate the development phase of its first micropeptide candidates in the United States and will build a locally-recruited team to deploy its solutions.

Founded in France in 2016 as a spin-off of “LRSV”, a Plant Research Laboratory at Centre National de la Recherche Scientifique (CNRS) and Toulouse University, a center of excellence in AgTech, Micropep has developed a technological platform that makes it possible to precisely regulate a plant’s gene expression, without altering its DNA, by the exogenous application of micropeptides, a family of proteins naturally produced by plants to respond to stress and regulate their development.